What ONCare Alliance does

ONCare Alliance is a national network of independent community oncology practices, formed in February 2024 through the merger of the National Cancer Care Alliance (NCCA) and the Quality Cancer Care Alliance (QCCA). The company serves 30 member practices located across more than 20 U.S. states, providing centralized tools, clinical trial access, advocacy, education and training, and a proprietary shared data engine that aggregates treatment data across the network to support real-world evidence generation and population health analysis. Representative research outputs include a 300-patient retrospective study of HER2-low metastatic breast cancer patients receiving T-DXd in community oncology settings and an AYVAKIT tolerability/persistence analysis from real-world ONCare data.

The core technology is a proprietary shared data engine that ingests and analyzes treatment, trend, and outcome data from member practices, supplemented in January 2025 by a multi-omics database and biobank partnership with Ovation.io aimed at accelerating biomarker discovery. ONCare distributes its offering through a layer of affiliate organizations that handle clinical trial operations (Exigent, P1 Trials), drug purchasing and pricing (Athena Oncology, Prism TPO), operational efficiency (Clarion), and training (Oncology College), along with the Cancer Safety Net Foundation for community-level support.

Revenue is generated through membership fees paid by independent oncology practices joining the network, structured as a recurring subscription. The go-to-motion is direct practice recruitment: ONCare invites mid-market independent oncology practices to join while preserving their clinical autonomy, and member practices gain access to the shared data engine, research collaborations, peer support, and group purchasing benefits. The organization is privately held, headquartered at 1624 S I St, Tacoma, Washington, and has not disclosed any external funding rounds; leadership is provided by a board of practicing oncologists led by Co-Chairs Dr. Sibel Blau (President/CEO) and Dr. Barbara McAneny (Chief Officer of Advocacy and Government Affairs).

Name

ONCare Alliance

Legal name

ONCare Alliance, LLC

Website

https://oncarealliance.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

ONCare Alliance is a national network of 30 independent community oncology practices across 20+ U.S. states, formed in February 2024 through the NCCA and QCCA merger, offering members a proprietary shared data engine, clinical trial access, group purchasing, and practice support services.

Ownership category

akta.pro rank

Product category

Community oncology network services

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Community oncology network
• Oncology practice support
• Clinical trial network
• Cancer care services
• Real-world evidence data

Headquarters

HQ city

Tacoma

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Member Practice Network Fees: Independent oncology practices pay membership fees to join the ONCare Alliance network, gaining access to centralized tools, research collaboration, data insights, practice enhancement strategies, group purchasing benefits, and peer support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

ONCare Alliance operates a national membership-based network of 30 independent community oncology practices, providing centralized tools, shared proprietary data infrastructure, collaborative research and clinical trial access, group purchasing, business and management training, and peer support services. Member practices pay recurring fees to access the collective network benefits while retaining clinical autonomy.

Product overview

ONCare Alliance is a platform/network of fiercely independent community oncology practices offering collaborative access to research, education, data-based projects, patient support services, and practice enhancement strategies. The core offering is the ONCare Alliance Network, which includes 30 independent oncology practices across the United States, supported by a proprietary shared data engine for analyzing treatments and trends. The network is supplemented by affiliated products including Exigent Research Network for clinical trial support, Oncology College for business and management training, P1 Trials for Phase 1 clinical trial access, Prism TPO for drug pricing transparency, Athena Oncology for coordinated drug purchasing, Cancer Safety Net Foundation for patient support, and Clarion for operational efficiency solutions.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• T-DXd tolerability demonstrated with 15% toxicity-related discontinuation rate in real-world community setting (similar to 16.2% in DESTINY-Breast04 trial)
• +1 more outcomes

Named customers31 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Ten partnerships are on record, tiered core and minor.

• Ovation.iocoreTechnology or Integration · 7 January 2025ONCare Alliance and Ovation.io partnered to create a multi-omics database and biobank to accelerate biomarker discovery in oncology. This partnership enables real-world evidence collection and advanced genomic data analysis across the network of member practices.
• National Cancer Care Alliance (NCCA)coreStrategic or Co-development Partner · 1 February 2024NCCA merged with Quality Cancer Care Alliance (QCCA) to form ONCare Alliance in February 2024. NCCA was one of the founding organizations of the merged entity.
• Quality Cancer Care Alliance (QCCA)coreStrategic or Co-development Partner · 1 February 2024QCCA merged with National Cancer Care Alliance (NCCA) to form ONCare Alliance in February 2024. QCCA was one of the founding organizations of the merged entity.
• ExigentcoreStrategic or Co-development PartnerExigent provides centralized support for clinical trials and proprietary data insight, democratizing access to cancer research starting at the point of care. An affiliate organization offering benefits to ONCare Alliance members.
• Oncology CollegecoreStrategic or Co-development PartnerTraining delivered by industry leaders available in-person, via virtual meetings and on-demand. Provides essential business, management and legal skills to ensure long-term viability of member practices.
• Cancer Safety Net FoundationminorStrategic or Co-development PartnerFunding local organizations making impact on social determinants of health in communities. Raises funds nationally through donations from donors, foundations, and corporations.
• ClarionminorStrategic or Co-development PartnerEmpowers members with solutions that boost operational and clinical efficiency, provide financial resources, and allow focus on delivering exceptional cancer care within communities.
• Athena OncologycoreStrategic or Co-development PartnerGroup of independent community oncology practices synchronizing, centralizing, and managing drug purchasing efforts for better long-term viability of member practices.
• Prism TPOminorStrategic or Co-development PartnerOffers independent medical practices upfront, transparent, and trustworthy drug pricing by eliminating over 80% of traditional pricing components such as retrospective distribution rebates.
• P1 TrialscoreStrategic or Co-development PartnerEmpowers community-based oncology clinics to participate in groundbreaking Phase 1 clinical trials, providing patients access to investigational new therapies close to home.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Tennessee Oncology: A large independent community oncology practice and clinical research site. Operates with similar autonomy and trial/research emphasis as member practices of ONCare Alliance.
• American Oncology Network: A physician-led community oncology network offering practice management, revenue cycle, and clinical trial access to independent practices. Directly comparable service bundle and member profile to ONCare Alliance.
• OneOncology: A platform partnership formed by independent oncology practices to share services, technology, and research. Functions almost identically to ONCare Alliance as a network enabling independent practice scale.
• Florida Cancer Specialists & Research Institute: One of the largest independent community oncology practices in the U.S., with research and clinical-trial infrastructure analogous to what ONCare Alliance aggregates across its member network.
• US Oncology Network: The largest U.S. community oncology practice network, backed by McKesson, providing centralized infrastructure, data, and pharma services to member practices. Directly comparable to ONCare Alliance in mission and operating model, though with greater scale and capital backing.

Others

• ASCO (American Society of Clinical Oncology): The leading professional society for oncologists, serving overlapping audiences (medical oncologists) and overlapping interests in research, education, and clinical-trial access relevant to ONCare's member practices.
• Ovation.io: Technology partner that co-developed ONCare's multi-omics database and biobank, providing the real-world evidence infrastructure layer that underpins ONCare's research product.
• Community Oncology Alliance: A non-profit advocacy organization that represents independent community oncology practices and is closely aligned with ONCare Alliance's mission to preserve independent practice models.

Broad incumbents

• McKesson (US Oncology Research): Parent of US Oncology Network with deep pharma services and real-world evidence capabilities across community oncology, a much larger incumbent against which ONCare Alliance competes for member practices and pharma data deals.
• Cardinal Health Specialty Solutions (Oncology): A major healthcare distributor whose specialty oncology solutions serve community oncology practices, overlapping with ONCare's drug-pricing and distribution-focused affiliates such as Prism TPO and Athena Oncology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/oncare-alliance

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ONCare Alliance